Abstract
The Ser/Leu-swapped genetic code can act as a genetic firewall, mitigating biohazard risks arising from horizontal gene transfer in genetically modified organisms. Our prior work demonstrated the orthogonality of this swapped code to the standard genetic code using a cell-free translation system comprised of 21 in vitro transcribed tRNAs. In this study, to advance this system for protein engineering, we introduce a natural/in vitro transcribed-hybrid tRNA set. This set combines natural tRNAs from Escherichia coli (excluding Ser, Leu, and Tyr) and in vitro transcribed tRNAs, encompassing anticodon-swapped tRNASerGAG and tRNALeuGGA. This approach reduces the number of in vitro transcribed tRNAs required from 21 to only 4. In this optimized system, the production of a model protein, superfolder green fluorescent protein, increases to 3.5-fold. With this hybrid tRNA set, the Ser/Leu-swapped cell-free translation system will stand as a potent tool for protein production with reduced biohazard concerns in future biological endeavors.
Similar content being viewed by others
Introduction
Bacterial synthesis of proteins using a genetically modified organism (GMO) transformed with a gene from pathogenic organisms poses biohazard risks. A hazardous gene in the GMO could be transferred to other natural organisms through horizontal gene transfer1,2,3. Such inadvertent gene transfers have the potential to cause significant harm to human and animal health, as well as to the environment. Cell-free translation systems may provide a safer alternative for protein synthesis as they do not involve GMOs. Nonetheless, there remains a risk of gene leakage during the template DNA preparation process, which usually includes cloning genes from chemically synthesized DNA fragments or natural sources such as cDNA or genomic DNA into plasmids within a GMO.
To address this issue, we previously introduced the Ser/Leu-swapped genetic code (Supplementary Fig. 1)4. This genetic code allows for the synthesis of a protein without requiring the preparation of a hazardous gene. In this genetic code, Ser is assigned to Leu codons and vice versa, by utilizing chimeric tRNASerGAG and tRNALeuGGA, both of which have swapped anticodons. Genes encoded by the Ser/Leu-swapped genetic code are not hazardous to natural organisms as they only produce Ser/Leu-swapped inactive proteins in nature.
However, the initial proof-of-concept version of the Ser/Leu-swapped cell-free translation system required the preparation of 21 tRNAs through in vitro transcription. This made the cell-free translation system impractical for protein synthesis. In addition, in vitro transcribed (IVT) tRNAs lack post-transcriptional modifications, while natural tRNAs extracted from Escherichia coli (E. coli) are reported to have, on average, 7.7 post-transcriptional modifications per molecule5. These modifications play diverse roles, including altering codon-amino acid correspondence6,7, modulating decoding efficiencies of synonymous codons8,9,10, promoting proper tRNA folding11,12,13,14,15,16, and facilitating the efficient recognition of tRNAs by aminoacyl-tRNA synthetases such as IleRS, GluRS, and LysRS17,18,19. The production of proteins dropped to 20% when replacing the natural tRNA extract with the IVT tRNA set.
In this study, we create the hybrid-SL tRNA set. This set consists of tRNASer, tRNALeu, and tRNATyr-deficient natural tRNAs extracted from E. coli, alongside IVT-tRNAPhe, tRNATyr, chimeric tRNASerGAG, and chimeric tRNALeuGGA. Utilizing this hybrid tRNA set, we establish a Ser/Leu-swapped cell-free translation system (Fig. 1) that achieves protein production efficiency comparable to a translation system using natural tRNAs.
Results and discussion
Construction of the natural/ IVT-hybrid tRNA set
E. coli has 37 tRNAs that decode 61 codons into 20 proteinogenic amino acids. Among these, tRNASer, tRNALeu, and tRNATyr are longer (85–93 bases) than the other tRNAs (74–77 bases) (Fig. 2a). This characteristic allows us to prepare a tRNASer and tRNALeu-deficient natural tRNA set without having to isolate each individual tRNA.
Initially, we analyzed the E. coli natural tRNA extract using denaturing PAGE containing urea (Fig. 2a, lane 1). The mobility of band I was consistent with that of IVT tRNASer, tRNALeu, and tRNATyr (Fig. 2a, lanes 3–5). Thus, we inferred that this band represents the natural tRNASer, tRNALeu, and tRNATyr. The Band II tRNAs were excised from the gel and purified (Fig. 2a, lane 2), and this tRNA mixture was defined as the ∆SLY natural tRNA set.
Subsequently, we prepared IVT tRNATyr, chimeric tRNASerGAG, and chimeric tRNALeuGGA using T7 RNA polymerase. We then combined these with the ∆SLY natural tRNA set to assemble the hybrid tRNA set for the Ser/Leu-swapped genetic code, which we termed the hybrid-SL tRNA set (Fig. 2b). Similarly, we assembled the hybrid-Std tRNA set for the standard genetic code using IVT tRNASer and tRNALeu instead of chimeric tRNAs. We also assembled a tRNA set with 21 IVT tRNAs for the Ser/Leu-swapped genetic code, termed the IVT21-SL tRNA set. Using one of these three tRNA sets, we prepared reconstituted cell-free translation systems for further study (Supplementary Fig. 2).
Synthesis of peptides in a cell-free translation system with the hybrid-Std tRNA set
To verify the accurate decoding of codons in the cell-free translation system using the hybrid-Std tRNA set, we first assessed the synthesis of P1 peptides (Met-Tyr-Tyr-Tyr-Xaa-Asp-Asp-Arg-Asp, where Xaa represents 17 types of amino acids; Fig. 3a). Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis demonstrated that all peptides were synthesized in the cell-free translation system (Fig. 3b top and Supplementary Figs. 3a and 4; calculated and observed masses are listed in Supplementary Table 1 and 2). Tricine SDS-PAGE analysis followed by autoradiography ([14C]-Asp labeling) showed comparable amounts of peptides synthesized across all samples (Fig. 3c and Supplementary Fig. 3b). These results suggest that the natural tRNA species corresponding to 17 natural amino acids in the ΔSLY natural tRNA set accurately decode the Xaa codon. Tyr insertion was unexpectedly observed for peptides with Glu, Phe, Trp, and Lys. This anomaly might be due to translational slippage on repeated Tyr codons preceding the Xaa codon. Various translational slippages, such as −1, −4, and +2 frameshifts at the NNA-AAC-AAG sequence in an E. coli cell-free translation system20, as well as +2 frameshift at the GUG-UG sequence and +6 ribosome hopping at the GUG-UGA-GUU sequence in E. coli21, have been reported. In addition, the depletion of an aminoacyl-tRNA that corresponds to an A-site codon can increase the −1 frameshifting in an E. coli cell-free translation system22. This suggests that the unexpected insertion of Tyr observed in the mass spectra might be due to the low concentration of aminoacyl-tRNAs of Glu, Phe, Trp, and Lys (vide infra).
Accuracy of Ser/Leu-swapping in a cell-free translation system with the hybrid-SL tRNA set
The presence of natural tRNASer and tRNALeu in the hybrid-SL tRNA set could compromise accurate translation in the Ser/Leu-swapped cell-free translation system, leading to the synthesis of proteins that contain both Ser and Leu at the same positions. Although PAGE analysis showed no detectable amount of natural tRNASer and tRNALeu in the ∆SLY natural tRNA set (Fig. 2a, lane 2), we verified the accuracy of Ser/Leu-swapping by translating P1 peptides (Met-Tyr-Tyr-Tyr-Xaa-Asp-Asp-Arg-Asp, where Xaa represents amino acid at UCU or CUU codons; Fig. 3a).
We synthesized model peptides with Ser or Leu at the Xaa position using a cell-free translation system with the hybrid-SL tRNA set. MALDI-TOF MS analysis confirmed the correct assignment of Ser and Leu to their respective swapped codons in the Ser/Leu-swapped genetic code without observable cross-contamination (Fig. 3b middle and Supplementary Table 1). Tricine SDS-PAGE analysis supported this result, as translated products showed a single intense band for each mRNA (Fig. 3c).
To determine the necessity of excluding natural tRNASer and tRNALeu from the natural tRNA extract, we also tested a mix of the natural tRNA extract with chimeric tRNASerGAG and tRNALeuGGA. MALDI-TO FMS (Fig. 3b bottom and Supplementary Table 1) and tricine SDS-PAGE (Fig. 3c) detected mixtures of peptides with Ser and Leu, confirming the importance of excluding the natural tRNASer and tRNALeu for the accurate Ser/Leu-swapping in the cell-free translation system.
Optimization of the hybrid tRNA set for protein translation
Next, we aimed to synthesize a model protein in the cell-free translation system using the hybrid-Std tRNA set. We utilized a standard sfGFP gene encoding superfolder GFP (sfGFP) according to the standard genetic code and measured sfGFP production by spectrofluorometry (Supplementary Fig. 5, gfp-Std-22C). Unexpectedly, the fluorescence intensity of sfGFP synthesized with the hybrid-Std tRNA set was below 5% of that synthesized with the natural tRNA extract (Supplementary Fig. 6a).
We hypothesized that the concentration of specific natural tRNA(s) might have decreased during the PAGE purification process. To identify these tRNA(s), we supplemented the cell-free system with IVT tRNAs. We divided 18 IVT tRNAs into four groups (Groups A–D) and evaluated the sfGFP fluorescence intensity. Notably, the addition of Group A tRNAs (including tRNAPhe, tRNALys, tRNATrp, tRNACys, and tRNAAla) substantially increased sfGFP production (Supplementary Fig. 6a). Further testing of individual tRNAs from Group A revealed that only tRNAPhe significantly boosted sfGFP production, to about 78% of the level achieved with the natural tRNA extract (Supplementary Fig. 6b). Denaturing PAGE analysis showed a smeared band for IVT tRNAPhe (Fig. 2a, lane 6), indicating partial loss of tRNAPhe during the PAGE purification. Consequently, we included IVT tRNAPhe in the hybrid tRNA sets for subsequent experiments.
Ser/Leu-swapped synthesis of sfGFP using the hybrid-SL tRNA set
To study the synthesis of the model protein sfGFP in the Ser/Leu-swapped cell-free translation system, we prepared a Ser/Leu-swapped sfGFP gene encoded according to the Ser/Leu-swapped genetic code (Supplementary Fig. 5, gfp-SL-22C). Native PAGE analysis showed that the amount of active sfGFP produced with the hybrid-SL tRNA set was comparable to that with the natural tRNA extract (Fig. 4a, lane 4 vs. 1). Furthermore, the amount of active sfGFP was significantly improved to 3.5-fold compared to that with the IVT21-SL tRNA set (Fig. 4a, lane 4 vs. 5). This result indicates that the cell-free translation system with the hybrid-SL tRNA set is useful for in vitro protein production.
We also studied the orthogonality of the Ser/Leu-swapped genetic code and the standard genetic code by translating the protein using mismatched tRNA set/gene combinations: i.e., the Ser/Leu-swapped sfGFP gene with the natural tRNA extract and the standard sfGFP gene with the hybrid-SL tRNA set. No active sfGFP was detected in either cell-free translation system (Fig. 4a, lanes 2 and 3). This lack of activity is ascribed to 30 mutations, comprising 10 Ser to Leu substitutions and 20 Leu to Ser substitutions (Supplementary Fig. 5), present in the translation products from mismatched tRNA set/gene combinations. Considering sfGFP is composed of 239 amino acids, the 30 residue Ser/Leu swaps constitute 13% of the protein. Autoradiography after native PAGE showed bands of different mobilities than active sfGFP, presumed to be misfolded or aggregated translation products (Fig. 4a, lanes 7 and 8). This hypothesis was supported by SDS-PAGE analysis, which showed a single band for each sample (Supplementary Fig. 7).
Comparison of hybrid-SL and IVT21-SL tRNA sets for translating genes encoded by 22 or 47 sense codons
Using the IVT21-SL tRNA set, only 35 of the 61 sense codons (Supplementary Fig. 2) are available to encode a protein, as the tRNA set consists of 21 IVT tRNAs. In contrast, 53 of the 61 sense codons are available to encode a protein when using the hybrid-SL tRNA set, as the tRNAs for 16 standard amino acids (excluding Ser, Leu, Tyr, and Phe) were isolated from the natural tRNA extract (Supplementary Fig. 2).
For this study, we used a Ser/Leu-swapped sfGFP gene containing 22 sense codons (Supplementary Fig. 5, gfp-SL-22C). To verify codon availability, we prepared another Ser/Leu-swapped sfGFP gene containing 47 sense codons (excluding rare codons) (Supplementary Fig. 5, gfp-SL-47C). The synthesis of inactive proteins in a cell-free translation system using the natural tRNA extract from this gene demonstrated the orthogonality of the Ser/Leu-swapped genetic code with 53 sense codons against the standard genetic code (Supplementary Fig. 8).
In the cell-free translation system with the hybrid-SL tRNA set, a similar amount of active sfGFP was synthesized from both genes (Fig. 4b, lanes 1, 2, 5, and 6), suggesting that at least 47 sense codons are available to encode a protein. In contrast, while sfGFP was synthesized from the Ser/Leu-swapped sfGFP gene containing 22 sense codons (Fig. 4b, lanes 4 and 8), none was produced from the gene containing 47 sense codons (Fig. 4b, lanes 3 and 7) in the cell-free translation system using the IVT21-SL tRNA set. This is attributed to the IVT21-SL tRNA set’s lack of tRNAs to decode 14 codons, representing 26% of the coding sequence, in the gfp-SL-47C gene.
In addition, we developed a translation system using a hybrid-SL tRNA set from an E. coli strain with tRNA genes for rare codons. This hybrid-SL tRNA set enhanced sfGFP production from a gene carrying 15 rare codons (Supplementary Fig. 9, pa-gfp-SL-RC15 and Supplementary Fig. 10). Recent research indicates that the codon choice impacts amino acid incorporation accuracy23 and protein folding by modulating translation rates24,25 for some proteins. Therefore, the cell-free translation system with the hybrid-SL tRNA set is potentially invaluable for gene design.
Ser/Leu-swapped synthesis of streptavidin and β-galactosidase using the hybrid-SL tRNA set
To demonstrate the synthesis of another model protein in the Ser/Leu-swapped cell-free translation system, we prepared a Ser/Leu-swapped streptavidin gene encoded according to the Ser/Leu-swapped genetic code (Supplementary Fig. 11, stv-SL). Before native PAGE analysis, fluorescent-labeled biotin was added to detect active streptavidin. The result showed that the amount of active streptavidin in the cell-free translation system with the hybrid-SL tRNA set was comparable to that with the natural tRNA extract (Supplementary Fig. 12, lane 4 vs. 1). When attempting to translate proteins using mismatched tRNA set/gene combinations, no active streptavidin was detected (Supplementary Fig. 12, lanes 2 and 3), consistent with the results from the sfGFP experiments. The cause of this result is attributed to 22 Ser/Leu-swapped codons in the gene constituted with 160 codons. A similar outcome was noted for a Ser/Leu-swapped β-galactosidase gene, with a total of 156 Ser/Leu-swapped codons within a 1040-codon gene (Supplementary Fig. 13, pa-gal-SL; Supplementary Fig. 14), though the protein production levels were too low for SDS-PAGE detection. These experiments conclusively demonstrated the orthogonality of the Ser/Leu-swapped genetic code in the synthesis of other proteins.
LC-MS analysis of peptides and proteins produced in the cell-free translation systems
To further examine the products synthesized in cell-free translation systems, we used liquid chromatography-mass spectrometry (LC-MS) analysis. We prepared M2 and M3 mRNAs, each containing CU(U/C) or UC(U/C) codons, to investigate the effects of amino acid misincorporation (Fig. 5) and frame-shifting on these mRNAs (Supplementary Fig. 15). In experiments with these mRNAs, peptides P2 and P3, which contain Ser at the Xaa position, were predominantly produced from mRNAs with CU(U/C) codons when using the hybrid-SL tRNA set (Fig. 5, middle row; Supplementary Table 3 and 4; Supplementary Figs. 16–25 for MS/MS data), aligning with findings presented in Fig. 3. A minor presence of Leu-containing P2 and P3 peptides was noted, likely due to residual tRNALeu in the ∆SLY natural tRNA set or the small amount of tRNALeu remaining in the purified ribosome and EF-Tu solutions used to prepare the cell-free translation system26. This by-product was also detected in samples without the chimeric tRNASerGAG (Fig. 5, bottom row; Supplementary Table 3 and 4; Supplementary Figs. 16–25 for MS/MS data). Notably, misreading led to P2 and P3 peptides containing Phe or Thr, and Pro or Thr, respectively, suggesting misreading at specific codon/anticodon pairs (Fig. 5, bottom row; Supplementary Table 3 and 4; Supplementary Figs. 16–25 for MS/MS data; Supplementary Fig. 26a). The relative abundance of these by-products varied between M2 and M3 mRNAs, indicating that misreading efficiency might be influenced by the mRNA context around the CU(U/C) codons. Similarly, for mRNAs with UC(U/C) codons, peptides P2 and P3 predominantly contained Leu, with Ser-containing peptides appearing as minor by-products, again likely due to residual tRNASer in the ∆SLY set or the purified ribosome and EF-Tu solutions. This pattern was also observed without chimeric tRNALeuGGA. Misreading also led to the incorporation of Phe or Thr in the P2 peptide, and Pro or Thr in the P3 peptide (Fig. 5, bottom row; Supplementary Table 3 and 4; Supplementary Figs. 16–25 for MS/MS data), attributed to mispairing at specific codon/anticodon interfaces (Supplementary Fig. 26b). The frequency of misreading products was also different between M2 and M3 mRNAs, which again suggested that the misreading frequency could depend on the mRNA context surrounding the CUU/C codons. The misincorporated amino acids in these codons align with previous research by Kato et al.27. Our results further emphasize that the frequency of codon misreading could be influenced by the mRNA context, as previously observed with UAG misreading28. Furthermore, Thr misincorporation persisted in translations of M3 mRNAs with UC(U/C) and CU(U/C) codons, potentially due to the suboptimal performance of seryl-tRNA synthetase and the heightened misreading frequency influenced by the mRNA context around these codons.
We also identified peptides generated from −2, −1, +1, or +3 frameshifts (Fig. 6 and Supplementary Figs. 27–30 for MS/MS data). The peptide with a −2 frameshift could be produced through the misinteraction of tRNALeuGAG with the UUC codon followed by a −2 frameshift that rearranges it to a canonical codon-anticodon pair, CUU-GAG (Supplementary Figs. 31, f1). The three peptides with a −1 frameshift could be produced through misinteraction of tRNAThr(V/G)GU with the CU(U/C) codon followed by a −1 frameshift that rearranges it to a codon-anticodon pair, UCU-(V/G)GU (Supplementary Figs. 31, f2–4). The other three peptides with a −1 frameshift could be produced through the interaction of tRNAProGGG with the CCC codon followed by a −1 frameshift that also results in a canonical codon-anticodon pair, CCC-GGG (Supplementary Figs. 31, f5–7). The two peptides with a + 1 frameshift could be produced through the interaction of tRNAProVGG with the CCC codon followed by a + 1 frameshift that also results in a canonical codon-anticodon pair, CCG-VGG (Supplementary Figs. 31, f8–9). Three peptides with + 1 or + 3 frameshifts were identified in the translation system with the hybrid-SL tRNA set without tRNALeuGGA, presumably to avoid the unassigned UCU codon (Supplementary Figs. 31, f10–12).
Given the reported loss of accurate decoding by chimeric tRNALeu(U/C)GA (misreading near-cognate UCU codon)29 and tRNAAlaCGA (misreading near-cognate UCA codon)30, we analyzed the misreading products from M2 mRNAs containing near-cognate codons (Supplementary Fig. 32). After adding chimeric tRNASerGAG and tRNALeuGGA to a translation system with the natural tRNA extract, we examined the products via LC-MS (Supplementary Figs. 33–35). Among them, we identified three peptides with Leu or Ser substitution, whose relative abundance against the original peptides increased upon the addition of the chimeric tRNAs. The relative abundance of the P2-4 peptide with Phe to Ser substitution, which could result from the misreading of the UUC near-cognate codon by the chimeric tRNASerGAG through a U/G mismatch at the first base, was increased from 0.004 to 0.12. In addition, the relative abundance of the P2-1 peptide with a Pro-to-Ser substitution increased from 0.012 to 0.037, and a Pro-to-Leu substitution increased from 0.001 to 0.011. These peptides could be produced by the misreading of the CCC near-cognate codon by the chimeric tRNASerGAG through a C/A mismatch at the second base or by the chimeric tRNALeuGGA through a C/A mismatch at the first base.
Finally, LC-MS analysis was conducted on proteins (Supplementary Fig. 36, pa-gfp-Std and pa-gfp-SL; Supplementary Fig. 37, pa-stv-Std and pa-stv-SL; Supplementary Fig. 13, pa-gal-Std and pa-gal-SL) synthesized from Ser/Leu-swapped genes to assess amino acid incorporation at the swapped codons. The analysis of model proteins purified using anti-PA tag antibody beads post-trypsin digestion yielded MS/MS data of five fragments encoded by DNA sequences with one Ser/Leu-swapped codon (Supplementary Figs. 38–40). The main product in the translation mixture with the hybrid-SL tRNA set contained Leu at the UCU codons (GFP_135, streptavidin_171, β-galactosidase_41, and 424) and Ser at the CUU codon (GFP_102). Leu incorporation at the GFP_102 CUU codon was also observed, likely due to residual tRNALeu in the ∆SLY natural tRNA set.
In summary, we successfully developed a cell-free translation system with the Ser/Leu-swapped genetic code, employing the hybrid-SL tRNA set. This hybrid tRNA set enhanced sfGFP production, achieving a 3.5-fold increase compared to the previously reported IVT21-SL tRNA set. This not only improves translation efficiency but also reduces the associated effort needed to prepare the tRNA set for constructing the Ser/Leu-swapped genetic code. Importantly, the majority of the natural tRNAs are retained in the hybrid-SL tRNA set, making 53 out of 61 sense codons available for designing Ser/Leu-swapped genes.
Notably, the chimeric tRNAs have been observed to elevate misreading rates of the UUC and CCC near-cognate codons, likely due to a U/G mismatch at the first or the second base, resulting in the incorporation of Ser and Leu instead of Phe or Pro. To accurately decode the remaining eight codons, seven distinct IVT chimeric tRNAs must be employed within the cell-free system. This requirement might affect translation fidelity, as these IVT chimeric tRNAs potentially exhibit reduced accuracy. Investigating the precision of these chimeric tRNAs is essential to fully develop the complete Ser/Leu-swapped genetic code. For instance, tRNA engineering such as optimizing the anticodon bases31 or implementing post-transcriptional modifications5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 might be necessary to diminish misreading. Alternatively, this error could be mitigated by finely tuning the concentration of each aminoacyl-tRNA within the system. Exploring the overall translation fidelity and the balance of aminoacyl-tRNA concentrations would provide valuable insights into how cells uphold their translational machinery.
Our findings also indicate that the production of peptides with frameshifts and those containing incorrect amino acids at the UCU/C and CUU/C positions is influenced by the surrounding mRNA sequences. This highlights the importance of careful gene design to avoid translation errors. Future research should explore how the context of mRNA sequences affects frameshifts and the incorporation of incorrect amino acids. In addition, our translation system exhibited a relatively high incidence of peptides or proteins with misincorporated amino acids. Given that our system is reconstituted, it may be missing key components that promote accurate translation. Identifying these missing elements could significantly improve the utility of the in vitro translation system, facilitating more effective protein production.
Our study also demonstrated that proteins translated from Ser/Leu-swapped model protein genes were inactive when translated in the cell-free translation system with the standard genetic code. This finding underscores the reduced risk of gene leakage to natural organisms when employing Ser/Leu-swapped genes. Conversely, our findings point to the increasing necessity for cyber biosecurity. To counter the potential chemical synthesis of DNA encoding dangerous genes, a guideline was established by the International Gene Synthesis Consortium32. This protocol involves rejecting the synthesis of any gene identified as hazardous through sequence screening within a database of pathogenic genomes. Yet, genes designed with a codon-swapped genetic code could potentially evade such screenings. Therefore, the adaptation of sequence screening techniques to identify codon-swapped patterns of hazardous genes will become increasingly crucial for cyber-biosecurity.
The concept of an orthogonal genetic code, especially one involving amino acid-swapping, has attracted significant attention33,34 since our report in 20204. Recently, Chin’s group reported on the prevention of a mobile genetic element transfer by reassigning the Ser UC(A/G) codons to Ala, His, or Pro using chimeric tRNAAla(U/C)GA, tRNAHis(U/C)GA, or tRNAPro(U/C)GA in a codon compressed E. coli30,35. Church’s group also reported that the prevention of phage replication by reassigning the Ser UC(A/G) codons to Leu using chimeric tRNALeu(U/C)GA29. In addition to in vivo approaches from other groups, our cell-free method offers promising avenues to mitigate future biohazard risks.
Methods
Materials
E. coli Rosetta™ 2 (DE3) strain (cat no. TRNAMRE-RO) and the natural tRNA extract derived from E. coli MRE600 strain (cat no. 71397) were purchased from Merck. Anti-PA tag antibody beads (cat no. 012-25841) were purchased from FUJIFILM Wako Pure Chemical Corporation. Synthetic DNAs containing gfp-Std-22C, gfp-SL-22C, pa-gfp-SL-RC5, pa-gfp-SL-RC9, pa-gfp-SL-RC15, stv-Std, stv-SL, pa-gal-Std, pa-gal-SL, pa-gfp-Std, pa-gfp-SL, pa-stv-Std, and pa-stv-SL genes were purchased from Integrated DNA Technologies and Genscript. A plasmid containing the gfp-SL-47C gene was purchased from Eurofins Genomics. Oligonucleotides were purchased from FASMAC. M1, M2, and M3 mRNAs encoding model peptides (Figs. 3a, 5, and Supplementary Data 1) and mRNAs encoding model proteins (Supplementary Figs. 5, 9, 11, 13, 36, and 37, and Supplementary Data 2) were prepared with the procedure described in Supplementary Method 1 (see Supplementary Data 3 for primer sequences). 21 IVT tRNAs (Supplementary Table 5) were also prepared with the procedure described in Supplementary Method 2 (see Supplementary Data 4 and 5 for primer sequences).
Preparation of ΔSLY natural tRNAs
A denaturing PAGE gel was prepared with acrylamide/bisacrylamide (37.5:1, 10%), 6 M urea, and TBE (44.5 mM tris·borate pH 8.0, 2 mM EDTA) in a large gel cassette [height = 15 cm, width = 15 cm, gel thickness = 2 mm, 1 well (depth = 2 cm, width = 5 cm)]. A loading sample containing the natural tRNA extract (200 µL; 50 mg/mL tRNA extract, 4 M urea, 12.5 mM EDTA pH 8.0) was applied to the gel. Electrophoresis was carried out at 300 V for 100 min at room temperature. Band II (Fig. 2a) was cut out, and then crushed using a mortar and pestle. The crushed gel was resuspended in 15 mL of 0.3 M NaCl, and the solution was shaken overnight at room temperature to elute the tRNAs. The gel debris was removed by centrifugation, and twice the volume of ethanol was added to the supernatant. The solution was incubated at –20 °C for 30 min and then centrifuged (4 °C, 15,000 × g, 15 min). After removing the supernatant, the precipitate was dissolved in 1 mL of ultra-pure water. After filtering through a 45 µm syringe filter (Millipore, cat no. SLCRX13NK) and treating with phenol/chloroform, tRNAs were pelleted by ethanol precipitation. The resultant pellet was air-dried and redissolved in 100 µL of ultra-pure water. This tRNA mixture was termed the ΔSLY natural tRNA set. Both the ΔSLY natural tRNA set and the 10 mg/mL natural tRNA extract were analyzed using denaturing PAGE (6 M urea, 10% acrylamide). The gel was stained with ethidium bromide, imaged using the Gel Doc EZ system (Bio-Rad), and analyzed with Image Lab software (Bio-Rad). The ΔSLY natural tRNA set stock solution was prepared by adding ultra-pure water to achieve the same concentration of band II tRNAs as in the 10 mg/mL natural tRNA extract. The concentration of the ΔSLY natural tRNA set stock solution was determined by OD at 260 nm. To construct the ΔSLY natural tRNA set for genes containing rare codons, total tRNA was extracted from E. coli strain Rosetta™ 2 (DE3) cells following Supplementary Method 336.
Preparation of tRNA stock solutions
The compositions of the IVT tRNA mix are listed in Supplementary Table 6. The tRNA stock solutions including the ΔSLY natural tRNA set and the natural tRNA extract were heated at 95 °C for 5 min and then cooled to 25 °C to refold tRNAs before the translation reaction.
Preparation of E. coli reconstituted cell-free translation systems
E. coli reconstituted cell-free translation systems were prepared in our previous work37. The composition of the translation system is listed in Supplementary Table 7. In general, the hybrid tRNA translation mixture (5 µL) containing the 0.6 mg/mL ΔSLY natural tRNA set and 10 µM of each IVT tRNA was prepared by adding 0.75 µL of the 4 mg/mL ΔSLY natural tRNA set stock solution and 0.5 µL of the IVT tRNA mix (100 µM each). The translation mixture also contained 0.5 mM of each of the 19 amino acids (except Asp) and 2 µM of mRNA. The translation reaction was performed at 37 °C for 3 hours. For peptide synthesis, 50 µM [14C]-Asp (Moravek, cat no. MC139) for autoradiography, 50 µM non-radioactive Asp for MALDI-TOF MS, or 500 µM non-radioactive Asp for LC-MS was used. For protein synthesis, a mixture of 50 µM [14C]-Asp and 150 µM non-radioactive Asp for autoradiography, 500 µM non-radioactive Asp for other experiments was used.
The translation mixture (5 µL) containing 1.5 mg/mL of the natural tRNA extract was prepared by adding 0.75 µL of the 10 mg/mL natural tRNA extract. The IVT21-SL translation mixture (5 µL) containing 10 µM of each IVT tRNA (21 kinds of IVT tRNAs) was prepared by adding 2 µL of the IVT tRNA mix (25 µM each) following Supplementary Method 24.
Analysis of translated products
The synthesized model peptides labeled with [14C]-Asp in the translation mixture were analyzed using 15% polyacrylamide tricine SDS-PAGE followed by autoradiography (Pharos Fx imager, Bio-Rad). Alternatively, reactions with Asp instead of [14C]-Asp were performed. Reaction mixtures (2 µL) were applied to SPE C-TIP KT200 columns (Nikkyo Technos), which had been equivalated by 15 µL of elution solution (80% acetonitrile, 0.5% acetic acid). The columns were washed with 15 µL of wash solution (4% acetonitrile, 0.5% acetic acid) twice. Peptides were eluted by 2 µL of matrix solution (saturated α-cyano-4-hydroxycinnamic acid, 80% acetonitrile, 0.5% acetic acid) and applied onto the MALDI sample plate. After dry-up, the samples were analyzed by MALDI-TOF MS (autoflex maX, Bruker).
The synthesized model proteins labeled with [14C]-Asp in the translation mixture were analyzed by 15% polyacrylamide native PAGE and SDS-PAGE followed by autoradiography (Pharos Fx imager, Bio-Rad). For sfGFP analysis, the gel was also analyzed by fluorescence detection (λex = 473 nm, LPB filter; Typhoon FLA 9000, GE Healthcare).
For streptavidin analysis, 2.5 µL of 2 µM Atto 488-biotin (Sigma-Aldrich, cat no. 30574) was added to 2.5 µL of the reaction mixture to label active streptavidin with fluorophore. The excess Atto 488-biotin was removed using streptavidin M280 magnetic beads (Thermo Fisher Scientific, cat no. 60210) before subjecting the samples to native PAGE. The gel after native PAGE was analyzed by fluorescence detection (ChemiDoc MP, Bio-RAD).
For β-galactosidase analysis, 2.5 µL of 100 µM Fluorescein di-β-D-galactopyranoside (Abcam, cat no. ab273643) was added to 2.5 µL of the translation mixture. After incubation at 37°C for 30 min, the solution was diluted 40 times with 25 mM Hepes-K pH7.5, and 150 mM NaCl and analyzed using fluorescence spectrometry (FP-8500, JASCO).
For optimization of the hybrid Std-tRNA set, the translation mixture (5 µL) containing synthesized sfGFP was diluted five times with 50 mM Tris-HCl pH8.0 and analyzed using fluorescence spectrometry (FP-8500, JASCO).
LC-MS/MS analysis of the translated products is described in the Supplementary Method 4 (see Supplementary Data 6 for the list of the FASTA and data files).
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
LC-MS data generated in this study have been deposited to ProteomeXchange with the identifier PXD050604. Source data are provided with this paper.
References
Dröge, M., Pühler, A. & Selbitschka, W. Horizontal gene transfer as a biosafety issue: a natural phenomenon of public concern. J. Biotechnol. 64, 75–90 (1998).
Ma, N. J. & Isaacs, F. J. Genomic recoding broadly obstructs the propagation of horizontally transferred genetic elements. Cell Syst. 3, 199–207 (2016).
Thomas, C. M. & Nielsen, K. M. Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat. Rev. Microbiol. 3, 711–721 (2005).
Fujino, T., Tozaki, M. & Murakami, H. An amino acid-swapped genetic code. ACS Synth. Biol. 9, 2703–2713 (2020).
Boccaletto, P. et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 50, D231–D235 (2022).
Muramatsu, T. et al. A novel lysine-substituted nucleoside in the first position of the anticodon of minor isoleucine tRNA from Escherichia coli. J. Biol. Chem. 263, 9261–9267 (1988).
Soma, A. et al. An RNA-modifying enzyme that governs both the codon and amino acid specificities of isoleucine tRNA. Mol. Cell 12, 689–698 (2003).
Takai, K., Okumura, S., Hosono, K., Yokoyama, S. & Takaku, H. A single uridine modification at the wobble position of an artificial tRNA enhances wobbling in an Escherichia coli cell-free translation system. FEBS Lett. 447, 1–4 (1999).
Kurata, S. et al. Modified uridines with C5-methylene substituents at the first position of the tRNA anticodon stabilize U.G wobble pairing during decoding. J. Biol. Chem. 283, 18801–18811 (2008).
Morris, R. C., Brown, K. G. & Elliott, M. S. The effect of queuosine on tRNA structure and function. J. Biomol. Struct. Dyn. 16, 757–774 (1999).
Cabello-Villegas, J., Tworowska, I. & Nikonowicz, E. P. Metal ion stabilization of the U-turn of the A37 N6-dimethylallyl-modified anticodon stem-loop of Escherichia coli tRNAPhe. Biochemistry 43, 55–66 (2004).
Dao, V. et al. Ribosome binding of DNA analogs of tRNA requires base modifications and supports the “extended anticodon”. Proc. Natl. Acad. Sci. USA 91, 2125–2129 (1994).
Konevega, A. L. et al. Purine bases at position 37 of tRNA stabilize codon-anticodon interaction in the ribosomal A site by stacking and Mg2+-dependent interactions. RNA 10, 90–101 (2004).
Yue, D., Kintanar, A. & Horowitz, J. Nucleoside modifications stabilize Mg2+ binding in Escherichia coli tRNA(Val): an imino proton NMR investigation. Biochemistry 33, 8905–8911 (1994).
Serebrov, V., Vassilenko, K., Kholod, N., Gross, H. J. & Kisselev, L. Mg2+ binding and structural stability of mature and in vitro synthesized unmodified Escherichia coli tRNAPhe. Nucleic Acids Res. 26, 2723–2728 (1998).
Arnez, J. G. & Steitz, T. A. Crystal structure of unmodified tRNA(Gln) complexed with glutaminyl-tRNA synthetase and ATP suggests a possible role for pseudo-uridines in stabilization of RNA structure. Biochemistry 33, 7560–7567 (1994).
Fukunaga, J., Ohno, S., Nishikawa, K. & Yokogawa, T. A base pair at the bottom of the anticodon stem is reciprocally preferred for discrimination of cognate tRNAs by Escherichia coli lysyl- and glutaminyl-tRNA synthetases. Nucleic Acids Res. 34, 3181–3188 (2006).
Sekine, S. et al. Major identity determinants in the “augmented D helix” of tRNA(Glu) from Escherichia coli. J. Mol. Biol. 256, 685–700 (1996).
Nureki, O. et al. Molecular recognition of the identity-determinant set of isoleucine transfer RNA from Escherichia coli. J. Mol. Biol. 236, 710–724 (1994).
Yan, S., Wen, J. D., Bustamante, C. & Tinoco, I. Ribosome excursions during mRNA translocation mediate broad branching of frameshift pathways. Cell 160, 870–881 (2015).
Atkins, J. F. & Björk, G. R. A gripping tale of ribosomal frameshifting: extragenic suppressors of frameshift mutations spotlight P-site realignment. Microbiol. Mol. Biol. Rev. 73, 178–210 (2009).
Caliskan, N. et al. Conditional switch between frameshifting regimes upon translation of dnaX mRNA. Mol. Cell 66, 558–567 (2017).
Sun, M. & Zhang, J. Preferred synonymous codons are translated more accurately: proteomic evidence, among-species variation, and mechanistic basis. Sci. Adv. 8, eabl9812 (2022).
Buhr, F. et al. Synonymous codons direct cotranslational folding toward different protein conformations. Mol. Cell 61, 341–351 (2016).
Sander, I. M., Chaney, J. L. & Clark, P. L. Expanding Anfinsen’s principle: contributions of synonymous codon selection to rational protein design. J. Am. Chem. Soc. 136, 858–861 (2014).
Miyachi, R., Shimizu, Y. & Ichihashi, N. Transfer RNA synthesis-coupled translation and DNA replication in a reconstituted transcription/translation system. ACS Synth. Biol. 11, 2791–2799 (2022).
Katoh, T. & Suga, H. A comprehensive analysis of translational misdecoding pattern and its implication on genetic code evolution. Nucleic Acids Res. 51, 10642–10652 (2023).
Umemoto, S., Kondo, T., Fujino, T., Hayashi, G. & Murakami, H. Large-scale analysis of mRNA sequences localized near the start and amber codons and their impact on the diversity of mRNA display libraries. Nucleic Acids Res. 51, 7465–7479 (2023).
Nyerges, A. et al. A swapped genetic code prevents viral infections and gene transfer. Nature 615, 720–727 (2023).
Zürcher, J. F. et al. Refactored genetic codes enable bidirectional genetic isolation. Science 378, 516–523 (2022).
Murakami, H., Ohta, A. & Suga, H. Bases in the anticodon loop of tRNA(Ala)(GGC) prevent misreading. Nat. Struct. Mol. Biol. 16, 353–358 (2009).
Harmonized screening protocol, I.G.S. v2.0. https://genesynthesisconsortium.org/wp-content/uploads/IGSCHarmonizedProtocol11-21-17.pdf (2017).
Kumar, S. & Hasty, J. Stability, robustness, and containment: preparing synthetic biology for real-world deployment. Curr. Opin. Biotechnol. 79, 102880 (2023).
Hoffmann, S. A. et al. Safety by design: biosafety and biosecurity in the age of synthetic genomics. iScience 26, 106165 (2023).
Robertson, W. E. et al. Sense codon reassignment enables viral resistance and encoded polymer synthesis. Science 372, 1057–1062 (2021).
Ehrenstein, G. Isolation of sRNA from intact Escherichia coli cells. Methods Enzymol. 12, 588–596 (1967).
Kondo, T. et al. Antibody-like proteins that capture and neutralize SARS-CoV-2. Sci. Adv. 6, eabd3916 (2020).
Acknowledgements
This study was financially supported by a Grant-in-Aid for Scientific Research(S) (grant number 23H05456 to H.M.), and a Grant-in-Aid for Scientific Research(C) (grant number 21K05270 to T.F.) from the Japan Society for the Promotion of Science and a donation from H. Murakami.
Author information
Authors and Affiliations
Contributions
Experiments were designed by T.F. and H.M. Samples were prepared by T.F., R.S., T.H. and H.M. Data except LC-MS analysis were acquired by T.F. and R.S. LC-MS data were acquired by E.M.S. and K.K. Figure design and manuscript writing were performed by T.F. and H.M. The project was supervised by H.M.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Norikazu Ichihash, Natalie Krahn, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fujino, T., Sonoda, R., Higashinagata, T. et al. Ser/Leu-swapped cell-free translation system constructed with natural/in vitro transcribed-hybrid tRNA set. Nat Commun 15, 4143 (2024). https://doi.org/10.1038/s41467-024-48056-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-024-48056-z
- Springer Nature Limited